Europe Guillain-Barre Syndrome Market Size, Share & Trends Analysis Report By Therapeutics (Intravenous Immunoglobulin, Plasma Exchange, and Others), By Route Of Administration, By Distribution Channel, By Country and Growth Forecast, 2023 - 2030

The Europe Guillain-Barre Syndrome Market would witness market growth of 4.4% CAGR during the forecast period (2023-2030).

The Germany market dominated the Europe Guillain-Barre Syndrome Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $57,999.6 Thousands by 2030. The UK market is exhibiting a CAGR of 3.5% during (2023 - 2030). Additionally, The France market would experience a CAGR of 5.2% during (2023 - 2030).

The applications of the Guillain-Barre syndrome market encompass various aspects of diagnosis, treatment, supportive care, and rehabilitation, all aimed at improving patient outcomes and quality of life. Accurate and timely diagnosis of GBS is essential for initiating appropriate treatment and managing the condition effectively.

Moreover, nerve conduction studies (NCS) measure the electrical signal intensity and speed as they travel along peripheral nerves to assess nerve function. Abnormalities in nerve conduction velocities and amplitudes indicate nerve damage characteristic of GBS.

Likewise, specialized neurology clinics in Spain, such as Hospital Clínic de Barcelona or Hospital Universitario La Paz in Madrid, are dedicated to diagnosing and managing neurological disorders, including GBS. Therefore, the market is growing due to the expansion of the healthcare industry and the development of rehabilitation facilities in the region.

Free Valuable Insights: The Global Guillain-Barre Syndrome Market will Hit USD 852.2 Million by 2030, at a CAGR of 4.6%

Based on Therapeutics, the market is segmented into Intravenous Immunoglobulin, Plasma Exchange, and Others. Based on Route of Administration, the market is segmented into Parenteral, and Oral. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled

• F.Hoffmann-La Roche Ltd.
• Pfizer, Inc.
• PTC, Inc.
• AstraZeneca PLC
• Novartis AG
• Novo Nordisk A/S
• Takeda Pharmaceutical Company Limited
• Bayer AG
• Merck & Co., Inc.
• Bristol Myers Squibb Company

Europe Guillain-Barre Syndrome Market Report Segmentation

By Therapeutics

• Intravenous Immunoglobulin
• Plasma Exchange
• Others

By Route Of Administration

• Parenteral
• Oral

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Others

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Guillain-Barre Syndrome Market, by Therapeutics
1.4.2 Europe Guillain-Barre Syndrome Market, by Route Of Administration
1.4.3 Europe Guillain-Barre Syndrome Market, by Distribution Channel
1.4.4 Europe Guillain-Barre Syndrome Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. Europe Guillain-Barre Syndrome Market by Therapeutics
4.1 Europe Intravenous Immunoglobulin Market by Country
4.2 Europe Plasma Exchange Market by Country
4.3 Europe Others Market by Country

Chapter 5. Europe Guillain-Barre Syndrome Market by Route Of Administration
5.1 Europe Parenteral Market by Country
5.2 Europe Oral Market by Country

Chapter 6. Europe Guillain-Barre Syndrome Market by Distribution Channel
6.1 Europe Hospital Pharmacies Market by Country
6.2 Europe Retail Pharmacies Market by Country
6.3 Europe Others Market by Country

Chapter 7. Europe Guillain-Barre Syndrome Market by Country
7.1 Germany Guillain-Barre Syndrome Market
7.1.1 Germany Guillain-Barre Syndrome Market by Therapeutics
7.1.2 Germany Guillain-Barre Syndrome Market by Route Of Administration
7.1.3 Germany Guillain-Barre Syndrome Market by Distribution Channel
7.2 UK Guillain-Barre Syndrome Market
7.2.1 UK Guillain-Barre Syndrome Market by Therapeutics
7.2.2 UK Guillain-Barre Syndrome Market by Route Of Administration
7.2.3 UK Guillain-Barre Syndrome Market by Distribution Channel
7.3 France Guillain-Barre Syndrome Market
7.3.1 France Guillain-Barre Syndrome Market by Therapeutics
7.3.2 France Guillain-Barre Syndrome Market by Route Of Administration
7.3.3 France Guillain-Barre Syndrome Market by Distribution Channel
7.4 Russia Guillain-Barre Syndrome Market
7.4.1 Russia Guillain-Barre Syndrome Market by Therapeutics
7.4.2 Russia Guillain-Barre Syndrome Market by Route Of Administration
7.4.3 Russia Guillain-Barre Syndrome Market by Distribution Channel
7.5 Spain Guillain-Barre Syndrome Market
7.5.1 Spain Guillain-Barre Syndrome Market by Therapeutics
7.5.2 Spain Guillain-Barre Syndrome Market by Route Of Administration
7.5.3 Spain Guillain-Barre Syndrome Market by Distribution Channel
7.6 Italy Guillain-Barre Syndrome Market
7.6.1 Italy Guillain-Barre Syndrome Market by Therapeutics
7.6.2 Italy Guillain-Barre Syndrome Market by Route Of Administration
7.6.3 Italy Guillain-Barre Syndrome Market by Distribution Channel
7.7 Rest of Europe Guillain-Barre Syndrome Market
7.7.1 Rest of Europe Guillain-Barre Syndrome Market by Therapeutics
7.7.2 Rest of Europe Guillain-Barre Syndrome Market by Route Of Administration
7.7.3 Rest of Europe Guillain-Barre Syndrome Market by Distribution Channel

Chapter 8. Company Profiles
8.1 F. Hoffmann-La Roche Ltd.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 SWOT Analysis
8.2 Pfizer, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional & Segmental Analysis
8.2.4 Research & Development Expense
8.2.5 SWOT Analysis
8.3 PTC, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 SWOT Analysis
8.4 AstraZeneca PLC
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 SWOT Analysis
8.5 Novartis AG
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.6 SWOT Analysis
8.6 Novo Nordisk A/S
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 SWOT Analysis
8.7 Takeda Pharmaceutical Company Limited
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expense
8.7.5 SWOT Analysis
8.8 Bayer AG
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.8.5 SWOT Analysis
8.9 Merck & Co., Inc.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 Recent strategies and developments:
8.9.5.1 Partnerships, Collaborations, and Agreements:
8.9.6 SWOT Analysis
8.10. Bristol Myers Squibb Company
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 SWOT Analysis

TABLE 1 Europe Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 2 Europe Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 3 Europe Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 4 Europe Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 5 Europe Intravenous Immunoglobulin Market by Country, 2019 - 2022, USD Thousands
TABLE 6 Europe Intravenous Immunoglobulin Market by Country, 2023 - 2030, USD Thousands
TABLE 7 Europe Plasma Exchange Market by Country, 2019 - 2022, USD Thousands
TABLE 8 Europe Plasma Exchange Market by Country, 2023 - 2030, USD Thousands
TABLE 9 Europe Others Market by Country, 2019 - 2022, USD Thousands
TABLE 10 Europe Others Market by Country, 2023 - 2030, USD Thousands
TABLE 11 Europe Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 12 Europe Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 13 Europe Parenteral Market by Country, 2019 - 2022, USD Thousands
TABLE 14 Europe Parenteral Market by Country, 2023 - 2030, USD Thousands
TABLE 15 Europe Oral Market by Country, 2019 - 2022, USD Thousands
TABLE 16 Europe Oral Market by Country, 2023 - 2030, USD Thousands
TABLE 17 Europe Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 18 Europe Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 19 Europe Hospital Pharmacies Market by Country, 2019 - 2022, USD Thousands
TABLE 20 Europe Hospital Pharmacies Market by Country, 2023 - 2030, USD Thousands
TABLE 21 Europe Retail Pharmacies Market by Country, 2019 - 2022, USD Thousands
TABLE 22 Europe Retail Pharmacies Market by Country, 2023 - 2030, USD Thousands
TABLE 23 Europe Others Market by Country, 2019 - 2022, USD Thousands
TABLE 24 Europe Others Market by Country, 2023 - 2030, USD Thousands
TABLE 25 Europe Guillain-Barre Syndrome Market by Country, 2019 - 2022, USD Thousands
TABLE 26 Europe Guillain-Barre Syndrome Market by Country, 2023 - 2030, USD Thousands
TABLE 27 Germany Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 28 Germany Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 29 Germany Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 30 Germany Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 31 Germany Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 32 Germany Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 33 Germany Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 34 Germany Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 35 UK Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 36 UK Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 37 UK Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 38 UK Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 39 UK Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 40 UK Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 41 UK Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 42 UK Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 43 France Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 44 France Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 45 France Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 46 France Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 47 France Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 48 France Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 49 France Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 50 France Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 51 Russia Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 52 Russia Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 53 Russia Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 54 Russia Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 55 Russia Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 56 Russia Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 57 Russia Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 58 Russia Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 59 Spain Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 60 Spain Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 61 Spain Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 62 Spain Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 63 Spain Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 64 Spain Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 65 Spain Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 66 Spain Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 67 Italy Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 68 Italy Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 69 Italy Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 70 Italy Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 71 Italy Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 72 Italy Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 73 Italy Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 74 Italy Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 75 Rest of Europe Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 76 Rest of Europe Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 77 Rest of Europe Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 78 Rest of Europe Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 79 Rest of Europe Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 80 Rest of Europe Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 81 Rest of Europe Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 82 Rest of Europe Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 83 Key Information – F. Hoffmann-La Roche Ltd.
TABLE 84 Key Information – Pfizer, Inc.
TABLE 85 key Information – PTC, Inc.
TABLE 86 KEY INFORMATION – AstraZeneca PLC
TABLE 87 Key Information – Novartis AG
TABLE 88 Key Information – Novo Nordisk A/S
TABLE 89 Key Information – Takeda Pharmaceutical Company Limited
TABLE 90 Key Information – Bayer AG
TABLE 91 Key Information - Merck & Co., Inc.
TABLE 92 Key Information – Bristol Myers Squibb Company

List of Figures
FIG 1 Methodology for the research
FIG 2 Europe Guillain-Barre Syndrome Market, 2019 - 2030, USD Thousands
FIG 3 Key Factors Impacting Guillain-Barre Syndrome Market
FIG 4 Porter’s Five Forces Analysis – Guillain-Barre Syndrome Market
FIG 5 Europe Guillain-Barre Syndrome Market share by Therapeutics, 2022
FIG 6 Europe Guillain-Barre Syndrome Market share by Therapeutics, 2030
FIG 7 Europe Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2030, USD Thousands
FIG 8 Europe Guillain-Barre Syndrome Market share by Route Of Administration, 2022
FIG 9 Europe Guillain-Barre Syndrome Market share by Route Of Administration, 2030
FIG 10 Europe Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2030, USD Thousands
FIG 11 Europe Guillain-Barre Syndrome Market share by Distribution Channel, 2022
FIG 12 Europe Guillain-Barre Syndrome Market share by Distribution Channel, 2030
FIG 13 Europe Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2030, USD Thousands
FIG 14 Europe Guillain-Barre Syndrome Market share by Country, 2022
FIG 15 Europe Guillain-Barre Syndrome Market share by Country, 2030
FIG 16 Europe Guillain-Barre Syndrome Market by Country, 2019 - 2030, USD Thousands
FIG 17 SWOT Analysis: F. Hoffmann-La Roche Ltd.
FIG 18 SWOT Analysis: Pfizer, Inc.
FIG 19 SWOT Analysis: PTC, Inc.
FIG 20 SWOT Analysis: AstraZeneca PLC
FIG 21 SWOT Analysis: Novartis AG
FIG 22 SWOT Analysis: Novo Nordisk A/S
FIG 23 SWOT Analysis:Takeda Pharmaceutical Company Limited
FIG 24 Swot Analysis: Bayer AG
FIG 25 SWOT Analysis: Merck & Co., Inc.
FIG 26 SWOT Analysis: Bristol Myers Squibb Company